CLINICAL_TRIALS
research
· 2017-11-30
Clinical Trial Update: Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia [NA]
Summary
This clinical trial update examines susceptibility to infections, tumor risk, and liver disease in patients with Ataxia Telangiectasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Ataxia Telangiectasia | NA | Status: UNKNOWN